Meanwhile, the MS rats treated with galangin and metformin at a dose of 50 mg/kg exhibited significantly improved expression of AdipoR1, COX-2, and p-NF-κB (p < 0.05) (Figure 8). This evidence concerns the gene NFKB1 and myeloid sarcoma.